![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1096-8652|93|3|467-468
ISSN: 0361-8609
Source: AMERICAN JOURNAL OF HEMATOLOGY, Vol.93, Iss.3, 2018-03, pp. : 467-468
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety of Imatinib in Chronic Myeloid Leukemia in Blastic Crisis Presenting as Cholestatic Jaundice
Acta Haematologica, Vol. 118, Iss. 3, 2007-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
More about Imatinib and Nilotinib Combination Therapy in Chronic Myeloid Leukemia
Acta Haematologica, Vol. 129, Iss. 1, 2012-09 ,pp. :